Gastric Cancer: A Multidisciplinary Approach

References

  1. Al-Batran SE, Hofheinz RD, Pauligk C, et al. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastroesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016/S1470-2045(16)30531-9. Epub 2016 Oct 22. PubMed PMID: 27776843.
  2. Burgain C, Germain A, Bastien C, et al. Computed tomography features of gastrointestinal linitis plastica: spectrum of findings in early and delayed phase imaging. Abdom Radiol (NY). 2016 Jul;41(7):1370-7. doi: 10.1007/s00261-016-0652-8. PubMed PMID: 26814502.
  3. Catino A, Lorusso V, Gargano G, et al. Metastatic involvement of the stomach secondary to breast carcinoma. A case report. Eur J Gynaecol Oncol. 1992;13(1 Suppl):85-8. PubMed PMID: 1324842.
  4. Cordier PY, Nau A, Ciccolini J, et al. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases. Cancer Chemother Pharmacol. 2011 Sep;68(3):823-6. doi: 10.1007/s00280-011-1666-0. Epub 2011 May 8. PubMed PMID: 21553285.
  5. Cunningham D, Allum WH, Stenning SP, et al, MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006 Jul 6;355(1):11-20. PubMed PMID: 16822992.
  6. Dixon M, Seevaratnam R, Wirtzfeld D, et al. A RAND/UCLA appropriateness study of the management of familial gastric cancer. Ann Surg Oncol. 2013 Feb;20(2):533-41. doi: 10.1245/s10434-012-2584-z. Epub 2012 Sep 1. PubMed PMID: 22941158.
  7. Elliott LA, Hall GD, Perren TJ, Spencer JA. Metastatic breast carcinoma involving the gastric antrum and duodenum: computed tomography appearances. Br J Radiol. 1995 Sep;68(813):970-2. PubMed PMID: 7496695.
  8. Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol. 2003 Dec;14(12):1705-13. Review. PubMed PMID: 14630673.
  9. Hansford S, Kaurah P, Li-Chang H, et al. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. JAMA Oncol. 2015 Apr;1(1):23-32. doi: 10.1001/jamaoncol.2014.168. Erratum in: JAMA Oncol. 2015 Apr;1(1):110. PubMed PMID: 26182300
  10. Hu B, El Hajj N, Sittler S, et al. Gastric cancer: Classification, histology and application of molecular pathology”. J Gastrointest Oncol. 2012; 3(3): 251–61. doi:10.3978/j.issn.2078-6891.2012.021. PMC 3418539. PMID 22943016.
  11. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000 Feb 15;88(4):921-32. PubMed PMID: 10679663.
  12. Jiang L, Yang KH, Chen Y, et al. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. Br J Surg. 2014 May;101(6):595-604.Epub 2014 Mar 25. Review. PubMed PMID: 24668465.
  13. Kaneko Y, Murray WK, Link E, et al. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer. J Nucl Med. 2015 Apr;56(4):523-9. doi: 10.2967/jnumed.114.150946. Epub 2015 Mar 5. Review. PubMed  PMID: 25745094.
  14. Ki SS, Jeong JM, Kim SH, et al. A case of neurotoxicity following 5-fluorouracil-based chemotherapy. Korean J Intern Med. 2002 Mar;17(1):73-7. PubMed PMID: 12014219; PubMed Central PMCID: PMC4531646.
  15. Kodali S, Bathini V, Rava P, Tipirneni E. Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil. J Gastrointest Cancer. 2017 Mar;48(1):66-69. doi: 10.1007/s12029-015-9797-x. PubMed PMID: 26744322.
  16. Koyama T, Sekine S, Taniguchi H, et al. Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas. Hum Pathol. 2011 Nov;42(11):1777-84. doi: 10.1016/j.humpath.2011.04.002. PubMed PMID:21733563.
  17. Lauwers GY, Carneiro F, Graham DY. Gastric carcinoma. In: Bowman FT, Carneiro F, Hruban RH, eds. Classification of Tumours of the Digestive System. Lyon: IARC; 2010.
  18. Lo W, Zhu B, Sabesan A, et al. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). J Med Genet. 2019 Feb 11. pii: jmedgenet-2018-105361. doi: 10.1136/jmedgenet-2018-105361. [Epub ahead of print] PubMed PMID: 30745422.
  19. Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018 Dec 5;9:1421. doi:10.3389/fphar.2018.01421. eCollection 2018. Review. PubMed PMID: 30568591; PubMed Central PMCID: PMC6290068.
  20. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001 Sep 6;345(10):725-30. PubMed PMID: 11547741.
  21. Schwarz RE, Klimstra DS, Turnbull AD. Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol. 1998 Jan;93(1):111-4. PubMed PMID: 9448188.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.